Compounding Pharmacy Market (2024 - 2034)
Compounding Pharmacy Market Study by Oral Medication, Topical Medication, Mouthwash, and Suppositories for Pain Management and Hormone Replacement Therapy from 2024 to 2034
Core Findings
Compounding Pharmacy Market Outlook (2024 to 2034)
The global compounding pharmacy market size is anticipated to reach a valuation of US$ 11.98 billion in 2024 and further expand at a CAGR of 8.5% to end up at US$ 27.03 billion by the year 2034.
A compounding pharmacy is a specialized type of pharmacy that is involved in the preparation of customized medications to meet the specific needs of individual patients. Unlike conventional pharmacies that dispense commercially available medications in standard forms and dosages, compounding pharmacies tailor medications based on a prescription from a healthcare provider.
Compounding pharmacists can alter the strength, dosage form, and even the flavor of a medication to accommodate a patient's unique requirements. Compounded medications can take various forms, including creams, gels, capsules, lozenges, and more.
Compounding pharmacies play a crucial role in providing personalized healthcare solutions, especially when commercially manufactured medications do not adequately meet the diverse needs of patients.
- North America is expected to hold 68.3% of the global compounding pharmacy market share by 2034.
Increasing emphasis on personalized healthcare in North America is leading to an increasing demand for customized medications tailored to individual patient needs
- The Latin American compounding pharmacy market size is evaluated at US$ 323 million for 2024.
Demand for customized medications for animals, including pets and livestock, is likely to boost the growth of the market for compounding pharmacies in Latin America during the forecast period. Veterinarians are likely to turn to compounding services to provide tailored medications for their patients, driving sales of vet compounding pharmacies.
Economic growth in Latin American countries is expected to influence healthcare spending and the willingness of individuals to invest in personalized healthcare solutions provided by compounding pharmacies.
| Report Attributes | Details |
|---|---|
| Compounding Pharmacy Market Size (2024E) | US$ 11.98 Billion |
| Forecasted Market Value (2034F) | US$ 27.03 Billion |
| Global Market Growth Rate (2024 to 2034) | 8.5% CAGR |
| Canada Market Value (2034F) | US$ 2.98 Billion |
| Topical Medication Demand Growth (2024 to 2034) | 8.2% CAGR |
| Key Companies Profiled | PharMEDium Services LLC; Nephron Pharmaceuticals Corporation; Rx3 Compounding Pharmacy; Fagron; B. Braun Melsungen AG Company; Athenex Pharma Solutions; Fresenius Kabi AG; Cantrell Drug Company; Clinigen Group PLC; Institutional Pharmacy Solutions; Dougherty's Pharmacy, Inc.; Lorraine's Pharmacy |
What Has Led to Increasing Popularity of Compounding Pharmacies?
“Personalized Medication Approach Driving Compounding Pharmacy Interest”
The compounding pharmacy market is increasing due to a notable shift towards a patient-centric healthcare approach. Traditionally, pharmaceutical interventions followed a one-size-fits-all approach, offering standardized medications to a broad patient population.
However, as healthcare paradigms are evolving, there is a growing recognition of the need for more personalized treatment options. This shift is driven by a deeper understanding of individual patient variability, including genetic factors, lifestyle choices, and unique health conditions.
Patients are increasingly seeking healthcare solutions that cater to their specific needs, taking into account factors such as allergies, sensitivities, and preferences.
This demand for personalized medicine is particularly prominent in cases where commercially available medications may not address individual requirements. Compounding pharmacies, with their ability to formulate customized medications, are strategically positioned to fulfil this growing demand for patient-centric healthcare.
“Rising Prevalence of Chronic Disorders Increasing Demand for Tailored Treatment and Medications”
Rising prevalence of chronic diseases represents a significant health challenge globally, with conditions such as diabetes, cardiovascular diseases, and chronic respiratory illnesses becoming increasingly common. This surge in chronic diseases is creating a notable compound pharmacy market trend, demanding more nuanced and personalized treatment approaches to effectively manage these complex and often lifelong conditions.
In response to this, compounding pharmacies are emerging as crucial players in providing tailored treatment plans that cater to the specific needs of patients grappling with chronic illnesses.
Chronic diseases often present unique challenges, requiring medication regimens that go beyond standard off-the-shelf solutions. Patients with chronic conditions may experience variations in symptoms, side effects, or responsiveness to medication, necessitating a more individualized approach to treatment.
Compounding pharmacies offer a flexible and customizable alternative to conventional medications, allowing healthcare providers to design treatment plans that are precisely tailored to the unique characteristics and needs of each patient. This is further fuelling the overall market growth.
What is a Major Restraint for Compounding Pharmacy Market Growth?
“Shortage of Skilled Professionals in Compounding Pharmacies”
The field of compounding pharmacy is intricately complex and specialized, requiring a high level of expertise, understanding, and experience from the laboratory technicians and pharmacists tasked with preparing compounded drugs.
Unlike traditional pharmacy settings where medications are dispensed in standardized forms, compounding involves the creation of personalized formulations tailored to meet the unique needs of individual patients. This demands a profound understanding of pharmaceutical science, dosages, compatibility of ingredients, and adherence to strict quality and safety standards.
Laboratory technicians and pharmacists in compounding pharmacies play a pivotal role in ensuring the precise and accurate preparation of compounded medications. They must possess in-depth knowledge of pharmaceutical compounding techniques, as well as a keen understanding of the diverse range of medications and dosage forms that may be required.
This includes expertise in adjusting drug concentrations, modifying dosage forms, and addressing specific patient requirements or restrictions. The scarcity of experts in the field of compounding pharmacy is emerging as a significant challenge and bottleneck for the overall market growth.
How are New Companies Expected to Shape their Success?
“Specialization and Niche Focus Effective Strategies to Run Ahead of Competition”
New companies should strategically choose specific therapeutic areas or niche markets to specialize in. By focusing on particular medical specialties or unique formulations, companies can differentiate themselves and establish a strong presence in a targeted segment. This approach helps in the development of specialized expertise and the creation of a unique value proposition.
Country-wise Analysis
Fact.MR, a market research and competitive intelligence provider estimates that the factors driving compounding pharmacy sales vary across the United States, Germany, and Brazil. However, the growing demand for personalized medicine, the rising prevalence of chronic disorders among the aging population, each country's unique healthcare landscape, regulatory environment, and cultural preferences are some of the common themes influencing the market growth in each country.
Why is Demand for Customized Medications Rising in the United States?
“Growing Geriatric Population with Chronic Disorders Contributing to Increasing Sales of Personalized Medicines”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 6.28 Billion |
| Growth Rate (2024 to 2034) | 9.3% CAGR |
| Projected Value (2034F) | US$ 15.26 Billion |
Aging population in the United States is leading to an upsurge in chronic conditions, necessitating tailored treatment plans including sterile compounded products. Compounding pharmacies offer flexibility in medication management, particularly beneficial for seniors with specific health requirements or challenges in traditional medication administration. Thus, the growing demand for personalized healthcare solutions in the United States is contributing significantly to the sales of compounding pharmacies.
What’s Increasing the Profits of Compounding Pharmacy Service Providers in Germany?
“Growing Focus on Dermatological Compounding Generating Ample Opportunities for Compounding Pharmacies”
Dermatological compounding demand is boosting in Germany. Compounded medications for skin conditions, such as eczema or psoriasis, offer specialized formulations that cater to individual patient needs are exhibiting growing demand in Germany.
Germany's healthcare system also places a strong emphasis on individualized therapies, driving the demand for compounding pharmacies. Patients’ value tailored treatment plans, and compounding pharmacies are well-positioned to meet these expectations.
What’s Driving Compounding Pharmacy Sales in Brazil?
“Cultural Acceptance of Herbal and Alternative Medicines Boosting Sales of Compounded Products”
| Attribute | Brazil |
|---|---|
| Market Value (2024E) | US$ 206 Million |
| Growth Rate (2024 to 2034) | 7.4% CAGR |
| Projected Value (2034F) | US$ 422 Million |
Brazil has a cultural inclination towards herbal and alternative medicines. Compounding pharmacies capitalize on this trend by formulating medications that incorporate herbal or alternative ingredients, catering to patient preferences, and contributing to sales growth.
Category-wise Analysis
Demand for compounded oral medications is driven by the ability of compounding pharmacies to provide personalized and patient-specific formulations. The flexibility to adjust dosage forms, flavors, strengths, and allergen content makes compounded oral medications a valuable option for individuals with diverse healthcare requirements, ultimately contributing to better patient outcomes and satisfaction.
Which Type of Compounded Medication is Widely Consumed?
“Pediatric and Geriatric Patients Key Consumers of Compounded Oral Medications”
| Attribute | Oral Medication |
|---|---|
| Segment Value (2024E) | US$ 5.39 Billion |
| Growth Rate (2024 to 2034) | 9.5% CAGR |
| Projected Value (2034F) | US$ 13.38 Billion |
Patients often have unique dosage requirements that may not be met by commercially available medications. Compounded oral medications can be flavored to improve palatability, making them more acceptable, especially for pediatric and geriatric patients who may have taste preferences or difficulty taking medication in standard forms. This customization enhances patient compliance, ensuring that individuals adhere to their prescribed treatment plans, further boosting the demand for combination therapies.
Customization, flexibility, and patient-centric approach offered by compounding pharmacies make them well-suited to meet the specific requirements of hormone replacement therapy (HRT). This tailored approach to HRT contributes significantly to the growth of compounding pharmacy sales, as more patients and healthcare providers recognize the benefits of personalized hormone formulations for achieving optimal therapeutic outcomes.
Will Hormone Replacement Therapy Drive Compounding Pharmacy Medication Sales?
“Personalized Hormone Formulations Exhibiting Increasing Demand to Achieve Effective Results”
| Attribute | Hormone Replacement Therapy |
|---|---|
| Segment Value (2024E) | US$ 4.08 Billion |
| Growth Rate (2024 to 2034) | 9.9% CAGR |
| Projected Value (2034F) | US$ 10.51 Billion |
Compounding pharmacies specialize in tailoring hormone formulations to the specific needs of individual patients. Unlike commercially available hormone medications, compounding allows for the creation of personalized formulations with precise hormone concentrations, ensuring that patients receive the most effective and individualized treatment.
Hormone replacement therapy (HRT) often involves the use of various hormones in specific combinations and dosages. Compounding pharmacies creates customized dosage forms such as creams, gels, troches, or capsules, providing patients with options that align with their preferences and optimize therapeutic outcomes.
Competitive Landscape
Key players in the compounding pharmacy market are adopting several approaches such as innovation, strategic collaborations, global expansion, and a patient-centric focus to earn high profits. By continually adapting to industry trends and embracing opportunities for growth and collaboration, leading companies are expected to position themselves as leaders in a competitive and evolving healthcare landscape.
- In February 2023, Harrow, a prominent United States eyecare pharmaceutical company, introduced its latest compounded Atropine formulations. These patent-pending formulations can be accessed through Harrow's compounding and mail-order pharmacy subsidiary, ImprimisRx.
Key Segments of Compounding Pharmacy Market Research
-
By Product :
- Oral Medication
- Topical Medication
- Mouthwash
- Suppositories
-
By Application :
- Medication for Adults
- Medication for Veterinary
- Medication for Children
- Medication for Geriatrics
-
By Therapeutic Area :
- Pain Management
- Hormone Replacement Therapy
- Others
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Background and Foundation Data Points
- 4. Global Market Demand (US$ Mn) Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 5. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Therapeutic Area
- 5.1. Pain Management
- 5.2. Hormone Replacement Therapy
- 5.3. Others
- 6. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Product
- 6.1. Oral Medication
- 6.2. Topical Medication
- 6.3. Mouthwash
- 6.4. Suppositories
- 7. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Application
- 7.1. Medication for Adults
- 7.2. Medication for Veterinary
- 7.3. Medication for Children
- 7.4. Medication for Geriatrics
- 8. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region
- 8.1. North America
- 8.2. Latin America
- 8.3. Europe
- 8.4. East Asia
- 8.5. South Asia & Oceania
- 8.6. Middle East and Africa (MEA)
- 9. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 10. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 11. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 12. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 13. South Asia & Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 14. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 15. Market Structure Analysis
- 16. Competition Analysis
- 16.1. PharMEDium Services LLC
- 16.2. Nephron Pharmaceuticals Corporation
- 16.3. Rx3 Compounding Pharmacy
- 16.4. Fagron
- 16.5. B. Braun Melsungen AG Company
- 16.6. Athenex Pharma Solutions
- 16.7. Fresenius Kabi AG
- 16.8. Cantrell Drug Company
- 16.9. Clinigen Group PLC
- 16.10. Institutional Pharmacy Solutions
- 16.11. Dougherty's Pharmacy, Inc.
- 16.12. Lorraine's Pharmacy
- 17. Assumptions and Acronyms Used
- 18. Research Methodology
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Therapeutic Area, 2018 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Therapeutic Area, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Therapeutic Area, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Product, 2018 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Therapeutic Area, 2018 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Therapeutic Area, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Therapeutic Area, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Product, 2018 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 28: Latin America Market Value (US$ Mn) Analysis, by Therapeutic Area, 2018 to 2023
Table 29: Latin America Market Value (US$ Mn) Analysis, by Therapeutic Area, 2024 to 2034
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Therapeutic Area, 2024 to 2034
Table 31: Latin America Market Value (US$ Mn) Analysis, by Product, 2018 to 2023
Table 32: Latin America Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 34: Latin America Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 35: Latin America Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Europe Market Value (US$ Mn) Analysis, by Therapeutic Area, 2018 to 2023
Table 41: Europe Market Value (US$ Mn) Analysis, by Therapeutic Area, 2024 to 2034
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Therapeutic Area, 2024 to 2034
Table 43: Europe Market Value (US$ Mn) Analysis, by Product, 2018 to 2023
Table 44: Europe Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 46: Europe Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 47: Europe Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 52: East Asia Market Value (US$ Mn) Analysis, by Therapeutic Area, 2018 to 2023
Table 53: East Asia Market Value (US$ Mn) Analysis, by Therapeutic Area, 2024 to 2034
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Therapeutic Area, 2024 to 2034
Table 55: East Asia Market Value (US$ Mn) Analysis, by Product, 2018 to 2023
Table 56: East Asia Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 58: East Asia Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 59: East Asia Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Therapeutic Area, 2018 to 2023
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Therapeutic Area, 2024 to 2034
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Therapeutic Area, 2024 to 2034
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2018 to 2023
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 76: MEA Market Value (US$ Mn) Analysis, by Therapeutic Area, 2018 to 2023
Table 77: MEA Market Value (US$ Mn) Analysis, by Therapeutic Area, 2024 to 2034
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Therapeutic Area, 2024 to 2034
Table 79: MEA Market Value (US$ Mn) Analysis, by Product, 2018 to 2023
Table 80: MEA Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 82: MEA Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 83: MEA Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Therapeutic Area, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Therapeutic Area, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Therapeutic Area, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Product, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Product, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Application, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Application, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 20: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 21: North America Market Share Analysis by Country, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by Therapeutic Area, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by Therapeutic Area, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Therapeutic Area, 2024 to 2034
Figure 27: North America Market Share and BPS Analysis by Product, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Product, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by Application, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by Application, 2024 to 2034
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 36: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 37: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 40: Latin America Market Share and BPS Analysis by Therapeutic Area, 2024 & 2034
Figure 41: Latin America Market Y-o-Y Growth Projections by Therapeutic Area, 2024 to 2034
Figure 42: Latin America Market Attractiveness Analysis by Therapeutic Area, 2024 to 2034
Figure 43: Latin America Market Share and BPS Analysis by Product, 2024 & 2034
Figure 44: Latin America Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis by Product, 2024 to 2034
Figure 46: Latin America Market Share and BPS Analysis by Application, 2024 & 2034
Figure 47: Latin America Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by Application, 2024 to 2034
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 52: Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 53: Europe Market Share Analysis by Country, 2024 & 2034
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 55: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 56: Europe Market Share and BPS Analysis by Therapeutic Area, 2024 & 2034
Figure 57: Europe Market Y-o-Y Growth Projections by Therapeutic Area, 2024 to 2034
Figure 58: Europe Market Attractiveness Analysis by Therapeutic Area, 2024 to 2034
Figure 59: Europe Market Share and BPS Analysis by Product, 2024 & 2034
Figure 60: Europe Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 61: Europe Market Attractiveness Analysis by Product, 2024 to 2034
Figure 62: Europe Market Share and BPS Analysis by Application, 2024 & 2034
Figure 63: Europe Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 64: Europe Market Attractiveness Analysis by Application, 2024 to 2034
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 68: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 69: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 71: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 72: East Asia Market Share and BPS Analysis by Therapeutic Area, 2024 & 2034
Figure 73: East Asia Market Y-o-Y Growth Projections by Therapeutic Area, 2024 to 2034
Figure 74: East Asia Market Attractiveness Analysis by Therapeutic Area, 2024 to 2034
Figure 75: East Asia Market Share and BPS Analysis by Product, 2024 & 2034
Figure 76: East Asia Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 77: East Asia Market Attractiveness Analysis by Product, 2024 to 2034
Figure 78: East Asia Market Share and BPS Analysis by Application, 2024 & 2034
Figure 79: East Asia Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 80: East Asia Market Attractiveness Analysis by Application, 2024 to 2034
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2024 to 2034
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2024 & 2034
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Therapeutic Area, 2024 & 2034
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Therapeutic Area, 2024 to 2034
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Therapeutic Area, 2024 to 2034
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Product, 2024 & 2034
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Product, 2024 to 2034
Figure 94: South Asia & Oceania Market Share and BPS Analysis by Application, 2024 & 2034
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 96: South Asia & Oceania Market Attractiveness Analysis by Application, 2024 to 2034
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 100: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 101: MEA Market Share Analysis by Country, 2024 & 2034
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 103: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 104: MEA Market Share and BPS Analysis by Therapeutic Area, 2024 & 2034
Figure 105: MEA Market Y-o-Y Growth Projections by Therapeutic Area, 2024 to 2034
Figure 106: MEA Market Attractiveness Analysis by Therapeutic Area, 2024 to 2034
Figure 107: MEA Market Share and BPS Analysis by Product, 2024 & 2034
Figure 108: MEA Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 109: MEA Market Attractiveness Analysis by Product, 2024 to 2034
Figure 110: MEA Market Share and BPS Analysis by Application, 2024 & 2034
Figure 111: MEA Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 112: MEA Market Attractiveness Analysis by Application, 2024 to 2034
- Frequently Asked Questions -
How big is the compounding pharmacy market in 2024?
The global compounding pharmacy market is calculated at US$ 11.98 billion for 2024.
What is the future of compounding pharmacies?
Revenue from compounding pharmacies is expected to increase at a CAGR of 8.5% from 2024 to 2034.
Is compounding pharmacy a profitable business?
Sales of compounding pharmacies are projected to reach US$ 27.03 billion by 2034.
What are the forecasted sales for compounding pharmacies in Chile?
The market in Chile is anticipated to reach US$ 148 million by 2034.
Which type of compounding pharmacy medications is widely sold?
Oral medication sales are foreseen to rise at a CAGR of 9.5% through 2034.
Who are the prime industry leaders?
Some of the leading companies include Institutional Pharmacy Solutions, Cantrell Drug Company, and B. Braun Melsungen AG Company.
Related Reports
Compounding Pharmacy Market